SE8804609L - Adenosinderivat - Google Patents

Adenosinderivat

Info

Publication number
SE8804609L
SE8804609L SE8804609A SE8804609A SE8804609L SE 8804609 L SE8804609 L SE 8804609L SE 8804609 A SE8804609 A SE 8804609A SE 8804609 A SE8804609 A SE 8804609A SE 8804609 L SE8804609 L SE 8804609L
Authority
SE
Sweden
Prior art keywords
compounds
formula
group
substituted
ring
Prior art date
Application number
SE8804609A
Other languages
English (en)
Swedish (sv)
Other versions
SE8804609D0 (sv
Inventor
B Evans
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8804609D0 publication Critical patent/SE8804609D0/xx
Publication of SE8804609L publication Critical patent/SE8804609L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8804609A 1987-12-23 1988-12-21 Adenosinderivat SE8804609L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878729994A GB8729994D0 (en) 1987-12-23 1987-12-23 Chemical compounds

Publications (2)

Publication Number Publication Date
SE8804609D0 SE8804609D0 (sv) 1988-12-21
SE8804609L true SE8804609L (sv) 1989-06-24

Family

ID=10628947

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8804609A SE8804609L (sv) 1987-12-23 1988-12-21 Adenosinderivat

Country Status (36)

Country Link
US (1) US5032583A (ja)
EP (1) EP0322242B1 (ja)
JP (1) JP2736088B2 (ja)
KR (1) KR890009967A (ja)
CN (1) CN1024198C (ja)
AT (1) ATA315488A (ja)
AU (2) AU612747B2 (ja)
BE (1) BE1002167A5 (ja)
CA (1) CA1320195C (ja)
CH (1) CH677495A5 (ja)
CZ (1) CZ403991A3 (ja)
DE (2) DE3856154T2 (ja)
DK (1) DK170894B1 (ja)
ES (1) ES2012927A6 (ja)
FI (1) FI90429C (ja)
FR (1) FR2629715B1 (ja)
GB (2) GB8729994D0 (ja)
GR (1) GR1000307B (ja)
HK (1) HK1009650A1 (ja)
HU (1) HU203364B (ja)
IE (1) IE61302B1 (ja)
IL (1) IL88765A (ja)
IT (1) IT1224840B (ja)
LU (1) LU87414A1 (ja)
MX (1) MX14331A (ja)
NL (1) NL8803140A (ja)
NO (1) NO171506C (ja)
NZ (1) NZ227485A (ja)
PH (1) PH25932A (ja)
PL (1) PL158800B1 (ja)
PT (1) PT89328B (ja)
RU (2) RU1826971C (ja)
SE (1) SE8804609L (ja)
SG (1) SG44701A1 (ja)
YU (1) YU234188A (ja)
ZA (1) ZA889593B (ja)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2226027B (en) * 1988-12-13 1992-05-20 Sandoz Ltd Adenosine derivatives,their production and use
FR2665362B1 (fr) * 1990-08-03 1994-12-09 Cepbepe Substance contenant, comme principe actif, une adenosine substitutee en n6 et son application.
AU654507B2 (en) * 1990-09-25 1994-11-10 Rhone-Poulenc Rorer International (Holdings) Inc. Compounds having antihypertensive and anti-ischemic properties
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
DK62692D0 (ja) * 1992-05-14 1992-05-14 Novo Nordisk As
US5672588A (en) * 1992-05-20 1997-09-30 Novo Nordisk A/S Purine derivatives
US5443836A (en) * 1993-03-15 1995-08-22 Gensia, Inc. Methods for protecting tissues and organs from ischemic damage
CA2186847A1 (en) * 1994-05-10 1995-11-16 Fulvio Gadient Adenosine derivatives
GB9421133D0 (en) * 1994-10-20 1994-12-07 Glaxo Group Ltd Medicaments
AU2022497A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
WO1997033591A1 (en) * 1996-03-13 1997-09-18 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
US6376472B1 (en) * 1996-07-08 2002-04-23 Aventis Pharmaceuticals, Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
IL139787A0 (en) 1998-06-02 2002-02-10 Osi Pharm Inc PYRROLO [2, 3d] PYRIMIDINE COMPOSITIONS AND THEIR USE
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
US6784165B1 (en) 1999-11-23 2004-08-31 Aderis Pharmaceuticals, Inc. Treatment of heart rhythm disturbances with N6-substituted-5′-(N-substituted) carboxamidoadenosines
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
US6294522B1 (en) * 1999-12-03 2001-09-25 Cv Therapeutics, Inc. N6 heterocyclic 8-modified adenosine derivatives
GB9930083D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
GB9930077D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
GB0106867D0 (en) 2001-03-20 2001-05-09 Glaxo Group Ltd Process
EP1258247A1 (en) * 2001-05-14 2002-11-20 Aventis Pharma Deutschland GmbH Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
DK1450811T3 (da) 2001-11-30 2010-02-15 Osi Pharm Inc Forbindelser specifikke af adenosin A1- og A3-receptorer og anvendelser heraf
CN1620294A (zh) 2001-12-20 2005-05-25 Osi药物公司 嘧啶a2b选择性拮抗剂化合物,它们的合成及用途
DE60236458D1 (de) 2001-12-20 2010-07-01 Osi Pharm Inc Pyrrolopyrimidin a2b selektive antagonistische verbindungen, deren synthese und verwendung
EP1633371A1 (en) * 2003-04-24 2006-03-15 Aderis Pharmaceuticals, Inc. Method of treating atrial fibrillation or atrial flutter
TWI494102B (zh) * 2003-05-02 2015-08-01 Japan Tobacco Inc 包含ｓ-〔２（〔〔１-（２-乙基丁基）環己基〕羰基〕胺基）苯基〕２-甲基丙烷硫酯及ｈｍｇ輔酶ａ還原酶抑制劑之組合
US20050118262A1 (en) * 2003-09-17 2005-06-02 Jack Aurora Controlled release formulation
CN101321460A (zh) * 2005-11-30 2008-12-10 伊诺泰克制药公司 嘌呤衍生物及其用法
CN101712709A (zh) * 2008-10-06 2010-05-26 中国医学科学院药物研究所 三乙酰基-3-羟基苯基腺苷及其调血脂的用途
JP5955769B2 (ja) * 2009-08-31 2016-07-20 ロンザ リミテッドＬｏｎｚａ Ｌｉｍｉｔｅｄ （１ｓ，４ｒ）−２−オキサ−３−アザビシクロ［２．２．１］ヘプト−５−エンの製造方法
TWI744723B (zh) 2014-06-20 2021-11-01 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130136C (ja) * 1966-10-20
NL6717061A (ja) * 1966-12-21 1968-06-24
DE2052596A1 (de) * 1970-10-27 1972-05-04 Boehringer Mannheim Gmbh, 6800 Mannheim Neuartige Verwendung von N(6)-substituierten Adenosin-Derivaten
NL7203984A (ja) * 1971-04-10 1972-10-12
BE788958A (fr) * 1971-09-18 1973-03-19 Schering Ag Derives d'adenosine et leur procede de preparation
DE2148838A1 (de) * 1971-09-30 1973-04-05 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2157036A1 (de) * 1971-11-17 1973-05-24 Boehringer Mannheim Gmbh Neue heterocyclisch substituierte nebularin-derivate und verfahren zu deren herstellung
DE2244328A1 (de) * 1972-09-09 1974-03-21 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2338705A1 (de) * 1973-07-31 1975-02-13 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2338963A1 (de) * 1973-08-01 1975-02-13 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
DE2426682A1 (de) * 1974-06-01 1975-12-11 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
ZA857998B (en) * 1984-10-26 1986-05-28 Warner Lambert Co N6-substituted adenosines
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines

Also Published As

Publication number Publication date
EP0322242A3 (en) 1990-04-18
EP0322242B1 (en) 1998-04-01
SG44701A1 (en) 1997-12-19
EP0322242A2 (en) 1989-06-28
NZ227485A (en) 1991-06-25
FI90429B (fi) 1993-10-29
FR2629715B1 (fr) 1993-09-03
GB8729994D0 (en) 1988-02-03
DE3856154T2 (de) 1998-08-27
NO885719D0 (no) 1988-12-22
US5032583A (en) 1991-07-16
ATA315488A (de) 1994-02-15
FI885943A (fi) 1989-06-24
ES2012927A6 (es) 1990-04-16
IL88765A (en) 1993-04-04
DK713488A (da) 1989-06-24
FR2629715A1 (fr) 1989-10-13
HUT48903A (en) 1989-07-28
DK713488D0 (da) 1988-12-21
YU234188A (en) 1990-12-31
PL276697A1 (en) 1990-02-19
KR890009967A (ko) 1989-08-05
MX14331A (es) 1993-12-01
AU8589491A (en) 1991-12-12
NL8803140A (nl) 1989-07-17
IT8848714A0 (it) 1988-12-23
ZA889593B (en) 1989-09-27
IT1224840B (it) 1990-10-24
DE3843609A1 (de) 1989-07-06
AU612747B2 (en) 1991-07-18
FI90429C (fi) 1994-02-10
CN1024198C (zh) 1994-04-13
CN1035295A (zh) 1989-09-06
GB2212498B (en) 1991-07-24
GR1000307B (el) 1992-05-12
NO885719L (no) 1989-06-26
PT89328A (pt) 1989-12-29
IE61302B1 (en) 1994-10-19
CH677495A5 (ja) 1991-05-31
HU203364B (en) 1991-07-29
RU2060996C1 (ru) 1996-05-27
PL158800B1 (en) 1992-10-30
NO171506C (no) 1993-03-24
JP2736088B2 (ja) 1998-04-02
DK170894B1 (da) 1996-03-04
JPH01203400A (ja) 1989-08-16
IE883845L (en) 1989-06-23
CZ403991A3 (en) 1993-04-14
PH25932A (en) 1991-12-19
SE8804609D0 (sv) 1988-12-21
IL88765A0 (en) 1989-07-31
LU87414A1 (fr) 1989-07-07
HK1009650A1 (en) 1999-06-04
NO171506B (no) 1992-12-14
GB8829983D0 (en) 1989-02-15
RU1826971C (ru) 1993-07-07
BE1002167A5 (fr) 1990-08-28
DE3856154D1 (de) 1998-05-07
GB2212498A (en) 1989-07-26
CA1320195C (en) 1993-07-13
AU2740188A (en) 1989-06-29
PT89328B (pt) 1993-08-31

Similar Documents

Publication Publication Date Title
SE8804609L (sv) Adenosinderivat
HUT54357A (en) Process for producing benzilidene-(azolylmethyl)-cycloalkane and -cycloalkene derivatives, fungicidal compositions comprising such compounds as active ingredient and intermediates usable for the production of the active ingredients
ES8607287A1 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
IL103301A0 (en) Pyrimidine nucleoside derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
HU9402239D0 (en) Isoxazole-derivatives, compositions containing them and processes for their preparation
EP0324387A3 (en) Composition for treatment of ischemic disorder in organs
DK0474243T3 (da) 1-methylcarbapenemderivater og fremgangsmåde til fremstilling deraf
UA27220C2 (uk) Спосіб одержання похідних 1-фенілімідазолін-2,5-діону
ES445928A1 (es) Procedimiento para la preparacion de compuestos de imidazo- linio cuaternarios.
MD422C2 (ro) Derivaţi ai azolului şi compuţi intermediari pentru producerea lor
MY108849A (en) Novel compound
ATE3111T1 (de) Verfahren zur herstellung von phenyl-propylmorpholin- und -piperidin-derivaten.
HU900840D0 (en) Process for preparation of aralkyl-amine-derivatives and compositions containing them
ES8200689A1 (es) Un procedimiento para la produccion de analogos de cefalosporina.
PL255529A1 (en) Method of obtaining novel n-alyl/en/o-n/",o-disubstituted thiophosphoryl/-n',n'-disubstituted glicinamides
HUT59930A (en) Process for producing bis-phosphonic acid derivatives and pharmaceutical compositions containing them as active component
BR8603787A (pt) Compostos heterociclicos,e,processo de sua preparacao e aplicacao
ES8304920A1 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
PT84367A (en) Process for the preparation of a fungicidal compound containing a naphthimidezolone
DE3062417D1 (en) Process for regulating plant growth
HU907489D0 (en) Process for the production of sulphonylkarbamide derivatives and herbicide preparations containing them as active agents
DE3471654D1 (en) Ûbis(hydroxymethyl)-methyl¨-isoquinoline derivatives, process for preparing them and pharmaceutical compositions containing them
DK480389D0 (da) Antitumorstof, fremgangsmaade til dets fremstilling og anticancermiddel indeholdende stoffet
ES2076212T3 (es) Derivado de maleimida, procedimiento para la preparacion del mismo, y fungicida agricola y horticola que contiene dicho derivado de maleimida como un ingrediente activo.
ES2025140B3 (es) Herbicidas heterociclicos.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8804609-9

Effective date: 19930701